Intrinsic value of R1 RCM - RCM

Previous Close

$8.79

  Intrinsic Value

$21.86

stock screener

  Rating & Target

str. buy

+149%

Previous close

$8.79

 
Intrinsic value

$21.86

 
Up/down potential

+149%

 
Rating

str. buy

We calculate the intrinsic value of RCM stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.0

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  459
  469
  481
  495
  510
  526
  544
  564
  585
  607
  631
  657
  684
  713
  744
  776
  811
  847
  886
  927
  970
  1,015
  1,063
  1,113
  1,166
  1,222
  1,280
  1,342
  1,407
  1,475
Variable operating expenses, $m
  228
  234
  240
  246
  254
  262
  271
  281
  291
  302
  314
  327
  341
  355
  370
  387
  404
  422
  441
  461
  483
  505
  529
  554
  581
  608
  638
  668
  701
  735
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  228
  234
  240
  246
  254
  262
  271
  281
  291
  302
  314
  327
  341
  355
  370
  387
  404
  422
  441
  461
  483
  505
  529
  554
  581
  608
  638
  668
  701
  735
Operating income, $m
  230
  236
  242
  248
  256
  264
  273
  283
  294
  305
  317
  330
  343
  358
  373
  390
  407
  425
  445
  465
  487
  509
  533
  559
  585
  613
  643
  674
  706
  741
EBITDA, $m
  239
  244
  250
  257
  265
  274
  283
  293
  304
  316
  328
  341
  356
  371
  387
  404
  422
  441
  461
  482
  504
  528
  553
  579
  606
  635
  666
  698
  732
  767
Interest expense (income), $m
  0
  0
  -3
  -3
  -3
  -2
  -2
  -2
  -1
  0
  0
  1
  1
  2
  3
  4
  5
  6
  7
  8
  9
  10
  11
  12
  14
  15
  17
  18
  20
  21
  23
Earnings before tax, $m
  230
  239
  245
  251
  258
  266
  275
  284
  294
  305
  316
  328
  341
  355
  370
  385
  401
  419
  437
  457
  477
  498
  521
  545
  570
  597
  625
  654
  685
  717
Tax expense, $m
  62
  65
  66
  68
  70
  72
  74
  77
  79
  82
  85
  89
  92
  96
  100
  104
  108
  113
  118
  123
  129
  135
  141
  147
  154
  161
  169
  177
  185
  194
Net income, $m
  168
  174
  179
  183
  189
  194
  201
  207
  215
  222
  231
  240
  249
  259
  270
  281
  293
  306
  319
  333
  348
  364
  380
  398
  416
  436
  456
  477
  500
  524

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  266
  272
  279
  287
  296
  305
  316
  327
  339
  352
  366
  381
  397
  414
  431
  450
  470
  491
  514
  537
  562
  589
  616
  646
  676
  709
  743
  778
  816
  856
Adjusted assets (=assets-cash), $m
  266
  272
  279
  287
  296
  305
  316
  327
  339
  352
  366
  381
  397
  414
  431
  450
  470
  491
  514
  537
  562
  589
  616
  646
  676
  709
  743
  778
  816
  856
Revenue / Adjusted assets
  1.726
  1.724
  1.724
  1.725
  1.723
  1.725
  1.722
  1.725
  1.726
  1.724
  1.724
  1.724
  1.723
  1.722
  1.726
  1.724
  1.726
  1.725
  1.724
  1.726
  1.726
  1.723
  1.726
  1.723
  1.725
  1.724
  1.723
  1.725
  1.724
  1.723
Average production assets, $m
  41
  42
  43
  45
  46
  47
  49
  51
  53
  55
  57
  59
  62
  64
  67
  70
  73
  76
  80
  83
  87
  91
  96
  100
  105
  110
  115
  121
  127
  133
Working capital, $m
  -54
  -55
  -56
  -58
  -60
  -62
  -64
  -66
  -68
  -71
  -74
  -77
  -80
  -83
  -87
  -91
  -95
  -99
  -104
  -108
  -113
  -119
  -124
  -130
  -136
  -143
  -150
  -157
  -165
  -173
Total debt, $m
  -63
  -58
  -51
  -44
  -36
  -28
  -18
  -8
  3
  14
  27
  40
  54
  70
  86
  103
  121
  140
  160
  181
  204
  227
  252
  278
  306
  335
  366
  398
  432
  468
Total liabilities, $m
  240
  245
  251
  258
  266
  275
  284
  294
  305
  317
  329
  343
  357
  372
  388
  405
  423
  442
  462
  484
  506
  530
  555
  581
  609
  638
  668
  701
  735
  770
Total equity, $m
  27
  27
  28
  29
  30
  31
  32
  33
  34
  35
  37
  38
  40
  41
  43
  45
  47
  49
  51
  54
  56
  59
  62
  65
  68
  71
  74
  78
  82
  86
Total liabilities and equity, $m
  267
  272
  279
  287
  296
  306
  316
  327
  339
  352
  366
  381
  397
  413
  431
  450
  470
  491
  513
  538
  562
  589
  617
  646
  677
  709
  742
  779
  817
  856
Debt-to-equity ratio
  -2.370
  -2.120
  -1.840
  -1.540
  -1.230
  -0.910
  -0.580
  -0.250
  0.080
  0.410
  0.730
  1.060
  1.370
  1.680
  1.990
  2.280
  2.570
  2.840
  3.110
  3.370
  3.620
  3.860
  4.090
  4.310
  4.530
  4.730
  4.930
  5.110
  5.290
  5.460
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  168
  174
  179
  183
  189
  194
  201
  207
  215
  222
  231
  240
  249
  259
  270
  281
  293
  306
  319
  333
  348
  364
  380
  398
  416
  436
  456
  477
  500
  524
Depreciation, amort., depletion, $m
  8
  8
  9
  9
  9
  9
  10
  10
  11
  11
  11
  12
  12
  13
  13
  14
  15
  15
  16
  17
  17
  18
  19
  20
  21
  22
  23
  24
  25
  27
Funds from operations, $m
  176
  183
  187
  192
  198
  204
  210
  217
  225
  233
  242
  251
  261
  272
  283
  295
  308
  321
  335
  350
  366
  382
  400
  418
  437
  458
  479
  502
  525
  550
Change in working capital, $m
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -7
  -8
  -8
Cash from operations, $m
  177
  184
  189
  194
  200
  206
  212
  220
  228
  236
  245
  254
  265
  275
  287
  299
  312
  325
  340
  355
  371
  387
  405
  424
  443
  464
  486
  509
  533
  558
Maintenance CAPEX, $m
  -8
  -8
  -8
  -9
  -9
  -9
  -9
  -10
  -10
  -11
  -11
  -11
  -12
  -12
  -13
  -13
  -14
  -15
  -15
  -16
  -17
  -17
  -18
  -19
  -20
  -21
  -22
  -23
  -24
  -25
New CAPEX, $m
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -5
  -6
  -6
  -6
Cash from investing activities, $m
  -9
  -9
  -9
  -10
  -10
  -10
  -11
  -12
  -12
  -13
  -13
  -13
  -14
  -15
  -16
  -16
  -17
  -18
  -18
  -20
  -21
  -21
  -22
  -24
  -25
  -26
  -27
  -29
  -30
  -31
Free cash flow, $m
  169
  175
  179
  184
  189
  195
  201
  208
  216
  223
  232
  241
  250
  260
  271
  283
  295
  307
  321
  335
  350
  366
  383
  400
  419
  438
  459
  480
  503
  527
Issuance/(repayment) of debt, $m
  -63
  6
  6
  7
  8
  9
  9
  10
  11
  12
  13
  13
  14
  15
  16
  17
  18
  19
  20
  21
  22
  24
  25
  26
  28
  29
  31
  32
  34
  36
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -63
  6
  6
  7
  8
  9
  9
  10
  11
  12
  13
  13
  14
  15
  16
  17
  18
  19
  20
  21
  22
  24
  25
  26
  28
  29
  31
  32
  34
  36
Total cash flow (excl. dividends), $m
  106
  180
  186
  191
  197
  204
  211
  218
  226
  235
  244
  254
  265
  276
  287
  300
  313
  326
  341
  356
  373
  390
  407
  426
  446
  467
  489
  512
  537
  562
Retained Cash Flow (-), $m
  -68
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -3
  -3
  -4
  -4
  -4
Prev. year cash balance distribution, $m
  75
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  112
  180
  185
  190
  196
  203
  210
  217
  225
  234
  243
  253
  263
  274
  285
  298
  311
  324
  339
  354
  370
  387
  405
  423
  443
  464
  486
  509
  533
  558
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  108
  165
  161
  157
  152
  147
  142
  136
  129
  123
  115
  108
  100
  92
  84
  76
  68
  60
  52
  45
  38
  32
  27
  22
  17
  14
  10
  8
  6
  4
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

R1 RCM Inc., formerly Accretive Health, Inc., is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

FINANCIAL RATIOS  of  R1 RCM (RCM)

Valuation Ratios
P/E Ratio 5.3
Price to Sales 1.6
Price to Book 5.9
Price to Tangible Book
Price to Cash Flow -10.8
Price to Free Cash Flow -9.4
Growth Rates
Sales Growth Rate 406.8%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -38.1%
Cap. Spend. - 3 Yr. Gr. Rate 45.4%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 40.5%
Ret/ On Assets - 3 Yr. Avg. 1.7%
Return On Total Capital -655.6%
Ret/ On T. Cap. - 3 Yr. Avg. -179.4%
Return On Equity -655.6%
Return On Equity - 3 Yr. Avg. -179.4%
Asset Turnover 1.4
Profitability Ratios
Gross Margin 66.3%
Gross Margin - 3 Yr. Avg. 11.7%
EBITDA Margin 51.9%
EBITDA Margin - 3 Yr. Avg. -38.5%
Operating Margin 50.3%
Oper. Margin - 3 Yr. Avg. -42.5%
Pre-Tax Margin 50.3%
Pre-Tax Margin - 3 Yr. Avg. -42.3%
Net Profit Margin 29.8%
Net Profit Margin - 3 Yr. Avg. -26.7%
Effective Tax Rate 40.6%
Eff/ Tax Rate - 3 Yr. Avg. 38.8%
Payout Ratio 0%

RCM stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the RCM stock intrinsic value calculation we used $449.8 million for the last fiscal year's total revenue generated by R1 RCM. The default revenue input number comes from 0001 income statement of R1 RCM. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our RCM stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for RCM is calculated based on our internal credit rating of R1 RCM, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of R1 RCM.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of RCM stock the variable cost ratio is equal to 49.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for RCM stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for R1 RCM.

Corporate tax rate of 27% is the nominal tax rate for R1 RCM. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the RCM stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for RCM are equal to 9%.

Life of production assets of 2.5 years is the average useful life of capital assets used in R1 RCM operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for RCM is equal to -11.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $33.4 million for R1 RCM - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 109.982 million for R1 RCM is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of R1 RCM at the current share price and the inputted number of shares is $1.0 billion.

RELATED COMPANIES Price Int.Val. Rating
NCI Navigant Consu 23.71 22.26  hold
IT Gartner 145.61 164.78  hold
HMSY HMS Holdings 36.13 10.86  str.sell

COMPANY NEWS

▶ R1 RCM Reports Third Quarter 2018 Results   [Nov-07-18 07:00AM  GlobeNewswire]
▶ R1 RCM to Release Third Quarter 2018 Results on November 7   [Oct-18-18 05:05PM  GlobeNewswire]
▶ Chardan: R1 RCM Will Make A Full Recovery   [Sep-04-18 02:41PM  Benzinga]
▶ R1 RCM Reports Second Quarter 2018 Results   [Aug-09-18 07:00AM  GlobeNewswire]
▶ R1 RCM Inc to Host Earnings Call   [06:00AM  ACCESSWIRE]
▶ R1 RCM to Release Second Quarter 2018 Results on August 9   [Jul-25-18 06:24PM  GlobeNewswire]
▶ R1 RCM Reports First Quarter 2018 Results   [May-09-18 07:00AM  GlobeNewswire]
▶ R1 Closes Acquisition of Intermedix Corporation   [May-08-18 04:05PM  GlobeNewswire]
▶ R1 RCM to Release First Quarter 2018 Results on May 9   [Apr-25-18 05:00PM  GlobeNewswire]
▶ R1 Appoints Alex Mandl as Lead Director   [Mar-26-18 05:00PM  GlobeNewswire]
▶ R1 RCM to Begin Trading on the Nasdaq Global Market   [Mar-20-18 05:00PM  GlobeNewswire]
▶ R1 RCM to Release Fourth Quarter 2017 Results on March 9   [Feb-27-18 05:00PM  GlobeNewswire]
▶ R1 to Acquire Intermedix Corporation   [06:00AM  GlobeNewswire]
▶ ETFs with exposure to R1 RCM, Inc. : December 12, 2017   [Dec-12-17 02:02PM  Capital Cube]
▶ ETFs with exposure to R1 RCM, Inc. : November 24, 2017   [Nov-24-17 10:51AM  Capital Cube]
▶ ETFs with exposure to R1 RCM, Inc. : November 13, 2017   [Nov-13-17 01:06PM  Capital Cube]
▶ ETFs with exposure to R1 RCM, Inc. : November 1, 2017   [Nov-01-17 12:35PM  Capital Cube]
▶ R1 RCM Reports Third Quarter 2017 Results   [Oct-31-17 04:04PM  GlobeNewswire]
▶ R1 RCM to Release Third Quarter 2017 Results on October 31   [Oct-18-17 08:00AM  GlobeNewswire]
▶ ETFs with exposure to R1 RCM, Inc. : October 10, 2017   [Oct-10-17 11:46AM  Capital Cube]
▶ ETFs with exposure to R1 RCM, Inc. : September 28, 2017   [Sep-28-17 10:18AM  Capital Cube]
▶ R1 RCM to Present at Two Upcoming Investor Conferences   [Aug-24-17 08:00AM  GlobeNewswire]
▶ R1 RCM Reports Second Quarter 2017 Results   [Aug-02-17 04:22PM  GlobeNewswire]
▶ R1 RCM Announces New Modular Revenue Cycle Solutions   [Jul-26-17 08:00AM  GlobeNewswire]
▶ ETFs with exposure to R1 RCM, Inc. : July 24, 2017   [Jul-24-17 06:34PM  Capital Cube]
▶ R1 RCM, Inc. Value Analysis (NASDAQ:RCM) : July 19, 2017   [Jul-19-17 01:27PM  Capital Cube]
▶ ETFs with exposure to R1 RCM, Inc. : July 14, 2017   [Jul-14-17 04:29PM  Capital Cube]
▶ ETFs with exposure to R1 RCM, Inc. : July 4, 2017   [Jul-04-17 03:24PM  Capital Cube]
▶ R1 RCM, Inc. Value Analysis (NASDAQ:RCM) : May 30, 2017   [May-30-17 01:10PM  Capital Cube]
▶ R1 RCM Reports First Quarter 2017 Results   [May-09-17 04:05PM  GlobeNewswire]
▶ R1 RCM to Release First Quarter 2017 Results on May 9   [Apr-25-17 08:00AM  GlobeNewswire]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.